IL117104A - Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents

Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL117104A
IL117104A IL117104A IL11710496A IL117104A IL 117104 A IL117104 A IL 117104A IL 117104 A IL117104 A IL 117104A IL 11710496 A IL11710496 A IL 11710496A IL 117104 A IL117104 A IL 117104A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
tetrahydrocarbazole derivatives
tetrahydrocarbazole
Prior art date
Application number
IL117104A
Other languages
English (en)
Other versions
IL117104A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117104(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL117104A0 publication Critical patent/IL117104A0/xx
Publication of IL117104A publication Critical patent/IL117104A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL117104A 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them IL117104A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
US08/167,846 US5464864A (en) 1991-06-26 1992-06-17 Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists
IL102322A IL102322A (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives for use as 5-ht1-like agonist medicaments

Publications (2)

Publication Number Publication Date
IL117104A0 IL117104A0 (en) 1996-06-18
IL117104A true IL117104A (en) 1997-09-30

Family

ID=10697363

Family Applications (4)

Application Number Title Priority Date Filing Date
IL11710596A IL117105A0 (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives process for their preparation and pharmaceutical compositions containing them
IL117105A IL117105A (en) 1991-06-26 1992-06-25 Derivatives of tetrahydrocarbazole process for their preparation and pharmaceutical preparations containing them
IL102322A IL102322A (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives for use as 5-ht1-like agonist medicaments
IL117104A IL117104A (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them

Family Applications Before (3)

Application Number Title Priority Date Filing Date
IL11710596A IL117105A0 (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives process for their preparation and pharmaceutical compositions containing them
IL117105A IL117105A (en) 1991-06-26 1992-06-25 Derivatives of tetrahydrocarbazole process for their preparation and pharmaceutical preparations containing them
IL102322A IL102322A (en) 1991-06-26 1992-06-25 Tetrahydrocarbazole derivatives for use as 5-ht1-like agonist medicaments

Country Status (35)

Country Link
US (2) US5464864A (ar)
EP (1) EP0591280B1 (ar)
JP (1) JP3261502B2 (ar)
KR (1) KR100251571B1 (ar)
CN (1) CN1034072C (ar)
AP (1) AP344A (ar)
AT (1) ATE170746T1 (ar)
BR (2) BR9206237A (ar)
CA (1) CA2113726C (ar)
CZ (3) CZ150696A3 (ar)
DE (2) DE69226953T2 (ar)
DK (1) DK0591280T3 (ar)
FI (1) FI103967B (ar)
GB (1) GB9113802D0 (ar)
HK (1) HK1014669A1 (ar)
HU (1) HU218907B (ar)
IE (1) IE922062A1 (ar)
IL (4) IL117105A0 (ar)
LU (1) LU90939I2 (ar)
MA (1) MA22563A1 (ar)
MX (1) MX9203444A (ar)
NL (1) NL300103I2 (ar)
NO (2) NO304774B1 (ar)
NZ (1) NZ243288A (ar)
PL (3) PL169392B1 (ar)
PT (1) PT100620B (ar)
RU (1) RU2137474C1 (ar)
SA (1) SA92130141B1 (ar)
SG (1) SG47877A1 (ar)
SI (1) SI9200125B (ar)
SK (3) SK280907B6 (ar)
TW (1) TW214544B (ar)
UA (1) UA41254C2 (ar)
WO (1) WO1993000086A1 (ar)
ZA (1) ZA924658B (ar)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
ES2151993T3 (es) * 1995-06-23 2001-01-16 Lilly Co Eli 1,2,3,4-tetrahidro-9h-carbazoles 6-sustituidos y 10h-ciclohepta(7,6-b)indoles 7-sustituidos.
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
ATE444965T1 (de) 2002-06-21 2009-10-15 Suven Life Sciences Ltd Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
MXPA04012832A (es) 2002-06-21 2005-05-27 Suven Life Sciences Ltd Arilsulfonil indoles novedosos que tienen afinidad por el receptor de la serotonina, utiles como agentes terapeuticos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
AU2003285759B2 (en) 2002-11-28 2010-01-28 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
ATE401307T1 (de) 2002-11-28 2008-08-15 Suven Life Sciences Ltd N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP1581538B1 (en) 2002-12-18 2007-02-28 Suven Life Sciences Limited Tetracyclic 3-substituted indoles having serotonin receptor affinity
EP2316824A1 (en) * 2006-08-07 2011-05-04 Actelion Pharmaceuticals Ltd. (3-Amino-1,2,3,4-tetrahydro-9H-carbazoI-9-yl)-acetic acid derivates
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5825757B2 (ja) 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするｄｈｅの治療上の投与方法
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
CA3066426A1 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
WO2011050140A1 (en) 2009-10-22 2011-04-28 Blue Fury Consulting, L.L.C. Posterior cervical fusion system and techniques
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
WO2013016223A2 (en) 2011-07-22 2013-01-31 The University Of Chicago Treatments for migraine and related disorders
WO2014100351A2 (en) 2012-12-21 2014-06-26 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions
EP2816030A1 (en) 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (de) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Tetrahydrocarbazolderivate

Also Published As

Publication number Publication date
UA41254C2 (uk) 2001-09-17
NL300103I1 (nl) 2002-12-02
AU1977592A (en) 1993-01-25
FI103967B1 (fi) 1999-10-29
NO934800L (no) 1993-12-23
WO1993000086A1 (en) 1993-01-07
IL117105A0 (en) 1996-06-18
DK0591280T3 (da) 1999-02-15
SK280905B6 (sk) 2000-09-12
DE10299042I1 (de) 2003-02-20
CA2113726A1 (en) 1993-01-07
AP344A (en) 1994-07-05
KR100251571B1 (ko) 2000-07-01
CZ286193A3 (en) 1994-07-13
CZ282327B6 (cs) 1997-06-11
NO2005011I1 (no) 2005-05-18
NL300103I2 (nl) 2003-02-03
IE922062A1 (en) 1992-12-30
MA22563A1 (fr) 1992-12-31
AP9200403A0 (en) 1992-07-31
NZ243288A (en) 1994-09-27
PL169392B1 (pl) 1996-07-31
MX9203444A (es) 1993-12-01
ZA924658B (en) 1993-12-24
FI103967B (fi) 1999-10-29
PT100620A (pt) 1993-09-30
SI9200125A (en) 1992-12-31
HU218907B (hu) 2000-12-28
NO304774B1 (no) 1999-02-15
PL171034B1 (en) 1997-02-28
EP0591280A1 (en) 1994-04-13
ATE170746T1 (de) 1998-09-15
LU90939I2 (fr) 2002-09-24
BR1100460A (pt) 2000-07-18
CZ150596A3 (en) 1997-05-14
PT100620B (pt) 1999-01-29
GB9113802D0 (en) 1991-08-14
CZ150696A3 (en) 1997-06-11
FI935842A0 (fi) 1993-12-23
PL169410B1 (pl) 1996-07-31
EP0591280B1 (en) 1998-09-09
SK280906B6 (sk) 2000-09-12
TW214544B (ar) 1993-10-11
CZ282083B6 (cs) 1997-05-14
SG47877A1 (en) 1998-04-17
SA92130141B1 (ar) 2005-12-18
NO2005011I2 (no) 2008-02-11
JPH06508827A (ja) 1994-10-06
RU2137474C1 (ru) 1999-09-20
BR9206237A (pt) 1995-04-11
SK131993A3 (en) 1994-06-08
CA2113726C (en) 2008-02-19
IL102322A (en) 1997-09-30
SK280907B6 (sk) 2000-09-12
HUT68961A (en) 1995-08-28
SI9200125B (en) 2001-12-31
US5637611A (en) 1997-06-10
US5464864A (en) 1995-11-07
CN1069726A (zh) 1993-03-10
JP3261502B2 (ja) 2002-03-04
FI935842A (fi) 1993-12-23
IL102322A0 (en) 1993-01-14
CZ282061B6 (cs) 1997-05-14
AU652842B2 (en) 1994-09-08
CN1034072C (zh) 1997-02-19
NO934800D0 (no) 1993-12-23
DE10299042I2 (de) 2005-02-03
HK1014669A1 (en) 1999-09-30
DE69226953D1 (de) 1998-10-15
DE69226953T2 (de) 1999-05-12
IL117105A (en) 1998-01-04
IL117104A0 (en) 1996-06-18

Similar Documents

Publication Publication Date Title
IL117104A (en) Tetrahydrocarbazole derivatives, process for their preparation and pharmaceutical compositions containing them
GR3032732T3 (en) Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.
HU9303252D0 (en) New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them
IL103126A (en) 5-amino-4-hydroxyhexanoic acid derivatives, process for their preparation and pharmaceutical compositions containing them
HUT72639A (en) Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation
IL96385A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
IL111314A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL105412A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
IL92798A0 (en) Benzimidazole derivatives,process for their preparation and pharmaceutical compositions containing them
IL86877A (en) Carbazole derivatives,their preparation and pharmaceutical compositions containing them
IL109703A0 (en) Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
IL109234A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL108859A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL97050A0 (en) 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation
HUT76065A (en) Indole derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9702400A3 (en) Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
IL110980A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL101042A0 (en) 3-piperidinyl-methylcarboxylate substituted indoles,their preparation and pharmaceutical compositions containing them
IL98542A0 (en) Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL112097A0 (en) Indoline derivatives, their preparation and pharmaceutical compositions containing them
HUP9602635A2 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL98864A0 (en) Oxazolyl derivatives,process for their preparation and pharmaceutical compositions containing them
HUT67014A (en) Benzofuran derivatives, pharmaceutical compositions containing them and process for the preparation of thereof
IL98812A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired